New therapeutic option for thromboembolism – dabigatran etexilate

Author： Nishio Hitoshi   Ieko Masahiro   Nakabayashi Toru  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.14, 2008-10, pp. : 2509-2517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dabigatran etexilate for venous thromboembolism: a safety evaluation

By Brown Richard   Lip Gregory YH   Gallego Pilar  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite

Dabigatran Etexilate

By Sanford Mark   Plosker Greg L.  

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1699-1709

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Review of its Use for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

By Burness Celeste B.   McKeage Kate  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 963-986

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal

By Holmes Michael   Carroll Christopher   Papaioannou Diana  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 137-146

Adis International

Access to resources Recommend Favorite

Important safety updates for dabigatran etexilate

By  

Reactions Weekly, Vol. 1, Iss. 1378, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite